Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs.

Publication Year: 2022

DOI:
10.1155/2022/6266528

PMCID:
PMC9705111

PMID:
36452412

Journal Information

Full Title: J Ophthalmol

Abbreviation: J Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure A preprint has previously been published [31]. Conflicts of Interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"This study was funded by the Project of Henan Science and Technology Development Plan (182102311209). The authors are particularly grateful to Ms. Yingying Xu, who as a nurse in the operating room of Henan Eye Hospital supplied the meticulous nursing supports of intravitreal injections for ROP."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025